Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells
September 10, 2010 by AboutNanoWires.com · Leave a Comment
Nanoporous Particles Deliver Novel Molecular Therapies to Tumors
May 28, 2010 by AboutNanoWires.com · Leave a Comment
Nanoporous Particles Deliver Novel Molecular Therapies to Tumors
(PhysOrg.com) — Using nanoporous silicon particles, two teams of investigators have created drug delivery vehicles capable of ferrying labile molecular therapies deep into the body. Both groups believe their new drug delivery vehicles create new opportunities for developing innovative anticancer therapies.
Read more on PhysOrg
Tiny Particles May Help Surgeons By Marking Brain Tumors
April 30, 2010 by AboutNanoWires.com · Leave a Comment
Tiny Particles May Help Surgeons By Marking Brain Tumors
Researchers have developed a way to enhance how brain tumors appear in MRI scans and during surgery, making the tumors easier for surgeons to identify and remove. Scientists at Ohio State University are experimenting with different nanoparticles that they hope may one day be injected into the blood of patients and help surgeons remove lethal brain tumors known as glioblastomas. In the journal …
Read more on Medical News Today
Research Reveals Cancer Drug Effectiveness Substantially Advanced
April 9, 2010 by AboutNanoWires.com · Leave a Comment
Research Reveals Cancer Drug Effectiveness Substantially Advanced
Co-administered peptide directs medicines to tumors and deep into tumor tissue, increasing drug efficacy and reducing side effects (PRWeb Apr 9, 2010) Read the full story at http://www.prweb.com/releases/cancer/drugs/prweb3853724.htm
Read more on PRWeb
Caltech-led Team Provides Proof in Humans of RNA Interference Using Targeted Nanoparticles
March 24, 2010 by AboutNanoWires.com · Leave a Comment
Caltech-led Team Provides Proof in Humans of RNA Interference Using Targeted Nanoparticles
A Caltech-led team of researchers and clinicians has published the first proof that a targeted nanoparticleused as an experimental therapeutic and injected directly into a patient’s bloodstreamcan traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi). Moreover, the team provided the …
Read more on Caltech Today
